Content about Delaware

WILMINGTON, Del. — Drug maker AstraZeneca is encouraging patients with asthma to control their disease and learn about how it may be affecting their lives as part of National Asthma and Allergy Awareness Month, which takes place in May.

NEW YORK — A hunger relief group serving Philadelphia and surrounding areas has hired a New York-based brand and retail design consultancy to design a prototype nonprofit grocery store to address food deserts.

The agency, CBX, said the Philabundance had hired it to design the store, Fare & Square, which will open this summer in Chester, Pa.

WILMINGTON, Del. — A federal court has ruled in favor of AstraZeneca in a case regarding a cholesterol drug, the company said.

AstraZeneca said the Court of Appeals for the Federal Circuit upheld a decision by the U.S. District Court for the District of Delaware ruling that a patent covering the drug Crestor (rosuvastatin calcium) was valid and enforceable. The patent, which expires in 2016, covers the active ingredient of Crestor.

LANDOVER, Md. — Giant Food is bringing back its A+ School Rewards program.

NEW CASTLE, Del. — ScripsAmerica last week announced that the company has secured $1 million in financing, which it will use to develop, manufacture and distribute its RapiMed brand of children's pain reliever and other core business products.

WILMINGTON, Del. — A survey released by Chase Slate with Blueprint revealed that more back-to-school shoppers are carefully managing their spending and borrowing by creating a budget and sticking to it.

Thirty-eight percent reported that they have a set budget for school-related expenses; in 2011, only 26% of people had created a budget for their back-to-school shopping. In addition, 32% said they anticipate their spending on back-to-school shopping this year to reflect prerecession figures.

PARSIPPANY, N.J. — The U.S. Court of Appeals for the Federal Circuit ruled in favor of Watson Pharmaceuticals during patent litigation concerning the drug maker's abbreviated new drug application for an overactive bladder treatment.

The appeals court affirmed a U.S. District Court for the District of Delaware's decision — made March 31 — that asserted that patents related to Allergan's Sanctura XR (trospium chloride extended-release capsules) are invalid. Watson's ANDA for a generic version of Sanctura XR is pending with the Food and Drug Administration.

WILMINGTON, Del. — AstraZeneca has launched a new drug for treating high blood pressure, the company said Thursday.

The Anglo-Swedish drug maker announced the launch of Dutoprol (metoprolol succinate extended-release and hydrochlorothiazide) tablets, calling it the first and only pill to combine the active ingredient of its Toprol-XL ER (metoprolol succinate) and hydrochlorothiazide.

LOS ANGELES — Marley Coffee has inked a distribution agreement that will expands its line's availability on the East Coast, as well as in Hawaii.

ENGLEWOOD CLIFFS, N.J. — Unilever’s Dove Hair has announced the real woman star of its new “Make Friends with Your Hair” television ad campaign.

The winner is Brittany Delaware, 23, of Teleford, Pa. Delaware joined women across the country and created a video of her own hair struggles for the campaign. America voted and Delaware was selected to receive a VIP trip to New York, a hair transformation from Dove celebrity stylist Mark Townsend and a starring role in the new Dove Hair TV ad.

SUPPLIER NEWS — The Medicines Co. and generic drug maker Teva Pharmaceutical Industries have reached a settlement that will allow Teva to start selling a generic version of one of MDCO’s drugs by the end of the decade. The drug makers announced the settlement in the U.S. District Court for the District of Delaware, whereby Teva can launch a generic version of the injectable anticoagulant drug Angiomax (bivalirudin) in June 2019.


BOULDER, Colo. — A fifth dietary supplement trade association may be in the early formulation stages, specifically designed to address the Food and Drug Administration's recent issues of New Dietary Ingredient guidance, according to a Nutrition Business Journal report published Wednesday.